ERA, BENEDETTA
 Distribuzione geografica
Continente #
EU - Europa 124.090
NA - Nord America 5.684
AS - Asia 2.909
SA - Sud America 445
AF - Africa 80
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 133.214
Nazione #
IT - Italia 122.667
US - Stati Uniti d'America 5.578
SG - Singapore 1.099
CN - Cina 940
SE - Svezia 349
BR - Brasile 344
VN - Vietnam 297
UA - Ucraina 253
DE - Germania 177
FI - Finlandia 147
FR - Francia 137
GB - Regno Unito 127
HK - Hong Kong 117
IN - India 84
KR - Corea 59
CA - Canada 58
BD - Bangladesh 54
JP - Giappone 45
NL - Olanda 40
AR - Argentina 35
TR - Turchia 33
PL - Polonia 31
AT - Austria 30
MX - Messico 27
IQ - Iraq 24
PK - Pakistan 22
ES - Italia 21
ZA - Sudafrica 21
ID - Indonesia 18
BE - Belgio 16
CO - Colombia 16
DZ - Algeria 16
UZ - Uzbekistan 16
RU - Federazione Russa 15
PH - Filippine 14
SA - Arabia Saudita 14
CZ - Repubblica Ceca 13
GR - Grecia 11
EC - Ecuador 10
IR - Iran 10
JO - Giordania 10
MA - Marocco 10
PY - Paraguay 10
VE - Venezuela 10
IE - Irlanda 9
TN - Tunisia 8
CH - Svizzera 7
TH - Thailandia 7
ET - Etiopia 6
KG - Kirghizistan 6
MY - Malesia 6
RO - Romania 6
CL - Cile 5
EG - Egitto 5
KE - Kenya 5
PE - Perù 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
NP - Nepal 4
TW - Taiwan 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
DK - Danimarca 2
EU - Europa 2
GY - Guiana 2
IL - Israele 2
LV - Lettonia 2
LY - Libia 2
MM - Myanmar 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
Totale 133.200
Città #
Cagliari 118.919
Uta 3.186
Singapore 602
Ashburn 555
Fairfield 473
Woodbridge 353
San Jose 341
Dallas 337
Chandler 288
Houston 262
Boardman 250
Nyköping 223
Wilmington 212
Beijing 194
Seattle 186
Cambridge 162
Ann Arbor 151
Jacksonville 139
Los Angeles 138
Council Bluffs 118
Dearborn 115
Hong Kong 102
New York 89
Helsinki 87
Santa Clara 82
The Dalles 75
Ho Chi Minh City 74
Lauterbourg 72
Hefei 65
Hanoi 61
Munich 55
Seoul 53
Shanghai 53
Boston 51
Dong Ket 46
Guangzhou 46
Nanjing 46
Buffalo 35
São Paulo 35
San Diego 34
Tokyo 33
Milan 29
Rome 29
Orem 27
Atlanta 25
Phoenix 25
Amsterdam 24
Redwood City 24
Redmond 23
Turin 22
Warsaw 22
Chicago 21
London 21
Chennai 20
Changsha 19
Frankfurt am Main 19
Rio de Janeiro 19
Shenyang 19
Toronto 19
Serramanna 18
Tianjin 17
Jiaxing 16
Montreal 16
Sassari 16
Vienna 16
Mumbai 15
Turku 15
Zhengzhou 15
Augusta 14
Brooklyn 14
Redondo Beach 14
Belo Horizonte 13
Brussels 13
Bultei 13
Hebei 13
Denver 12
Haiphong 12
Nanchang 12
Nuremberg 12
Tashkent 12
Baghdad 11
Da Nang 10
Johannesburg 10
Messina 10
Poplar 10
Siracusa 10
Torino 10
Jinan 9
Kunming 9
Lappeenranta 9
New Delhi 9
Putignano 9
San Mateo 9
Stockholm 9
Wuhan 9
Norwalk 8
Osasco 8
Taizhou 8
Amman 7
Ankara 7
Totale 129.284
Nome #
Plasma phospholipase, γ-CEHC and antioxidant capacity in fibromyalgia 4.325
Chemical composition of Lycium europaeum fruit oil obtained by supercritical CO2 extraction and evaluation of its antioxidant activity, cytotoxicity and cell absorption 4.263
Metabolomics analysis and modeling suggest a lysophosphocholines-PAF Receptor interaction in fibromyalgia 4.206
Evaluation of antioxidant and tyrosinase inhibitory activities ofthe extracts of Sarcopoterium spinosum (L.) Spach fruits 4.022
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease 3.746
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling 3.711
Selected Enzyme Inhibitory Effects of Euphorbia characias Extracts 3.556
Supercritical CO2 Extraction of Waste Citrus Seeds: Chemical Composition, Nutritional and Biological Properties of Edible Fixed Oils 3.492
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies 3.437
Sardinian honeys as sources of xanthine oxidase and tyrosinase inhibitors 3.433
Purine metabolites in fibromyalgia syndrome 3.433
Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins 3.424
Evaluation of antioxidant activities and chemical composition of Washingtonia filifera extracts. 3.311
Tyrosinase inhibition and antioxidant properties of Asphodelus microcarpus extracts 3.220
Phytochemical composition and the cholinesterase and xanthine oxidase inhibitory properties of seed extracts from the Washingtonia filifera palm fruit. 3.209
Design and discovery of tyrosinase inhibitors based on a coumarin scaffold 3.178
Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives 3.168
Coumarin derivatives as promising xanthine oxidase inhibitors 3.156
Free amino acids in fibromyalgia syndrome: relationship with clinical picture 3.124
Chemical composition and enzyme inhibition of Phytolacca dioica L. seeds extracts 2.995
Soluble adenosine deaminase activity in fibromyalgia syndrome 2.893
Structural and functional characterization of a new double variant haemoglobin (HbG-Philadelphia/Duarte α268Asn→Lys β262Ala→Pro) 2.737
null 2.542
Isolation of fixed oils using supercritical CO2 extraction. 2.313
Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans 2.312
Supercritical extraction of volatile and fixed oils from Petroselinum crispum L. seeds: chemical composition and biological activity 2.296
Anti-aging potential of extracts from Washingtonia filifera seeds 2.170
null 2.097
Tyrosine-like condensed derivatives as tyrosinase inhibitors 2.018
New halogenated phenylcoumarins as tyrosinase inhibitors 1.975
SYNTHESIS AND TYROSINASE INHIBITORY ACTIVITY OF BIS-COUMARIN RESVERATROL COUMARINS 1.818
A new β chain hemoglobin variant with increased oxygen affinity: Hb Santa Giusta Sardegna [β93(F9)Cys→Trp; HBB c.282T>G] 1.696
SYNTHESIS AND BIOLOGICAL EVALUATION OF BIS-SALICYLALDEHYDE AS MUSHROOM TYROSINASE INHIBITOR 1.670
null 1.641
Synthesis and Biological Evaluation of Bis-salicylaldehydes as Mushroom Tyrosinase Inhibitors 1.525
A new biological prospective for the 2-phenylbenzofurans as inhibitors of α-glucosidase and of the islet amyloid polypeptide formation 1.519
Washingtonia filifera seed extracts inhibit the islet amyloid polypeptide fibrils formations and α-amylase and α-glucosidase activity 1.277
Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids 1.200
null 1.199
null 1.198
Evidences of Xenon-Induced Structural Changes in the Active Site of Cyano-MetMyoglobins: A 1H NMR Study 1.123
Euphorbia characias: Phytochemistry and Biological Activities 1.010
Hb Belfast [β15(A12)Trp→Arg]: Definition of the clinical and hematological phenotype 957
null 947
New halogenated 3-phenylcoumarins as tyrosinase inhibitors 929
Euphorbia characias Extract: Inhibition of Skin Aging-Related Enzymes and Nanoformulation 910
Structural insight of new butyrylcholinesterase inhibitors based on benzylbenzofuran scaffold 871
A preliminary study on serum proteomics in fibromyalgia syndrome 800
null 791
DEVELOPMENT OF MULTI-TASK MODELS QSAR FOR RESEARCH OF TYROSINASE INHIBITORS 767
Arylicoumarins as new tyrosinase inhibitors 749
Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor 677
Hydroxylated Coumarin-Based Thiosemicarbazones as Dual Antityrosinase and Antioxidant Agents 671
null 662
TYROSINASE INHIBITOR ACTIVITY OF THE COUMARIN-RESVERATROL HYBRIDS 660
Hydroxy derivatives of 3-arylcoumarins as tyrosinase inhibitors 646
SOLUBLE ADENOSINE DEAMINASE ACTIVITY IN FIBROMYALGIA SYNDROME 596
Tempranillo Grape Extract in Transfersomes: A Nanoproduct with Antioxidant Activity 566
null 552
Phenylbenzofurans: Inhibitors and/or Activators for Mushroom Tyrosinase? 550
Phenylbenzofurans:inhibitors and/or activators for mushroom tyrosinase? 544
URINARY PURINE AND PYRIMIDINE INCREASE IN PATIENTS WITH METHYLMALONIC ACIDURIA COMBINED TO HOMOCYSTINURIA 529
Advances in Sardinian Withania somnifera (L.) Dunal crops through phytochemical and biological approaches 525
null 501
Synthesis and tyrosinase inhibitor activity of biscoumarin-resveratrol ibrids. 495
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes 493
Promising inhibition of diabetes-related enzymes and antioxidant properties of Ptilostemon casabonae leaves extract 493
Synthesis of a series of 2-phenylbenzofurans. Structure with rigid trans-resveratrol’s core and their tyrosinase activity. 489
Design of 3-Phenylcoumarins and 3-Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies 448
Increase in urinary purines and pyrimidines in patients with methylmalonic aciduria combined with homocystinuria 430
Tyrosinase inhibitor activity of a new series of bis-salicylaldehydes 406
Identificazione e caratterizzazione di una doppia variante emoglobinica: Hb G-Philadelphia [68 (E17) Asn —› Lys] Hb Duarte [62 (E6) Ala —› Pro]. 382
Phytochemical Composition and Biological Activity 361
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies 357
A New Class of Benzo[b]thiophene-chalcones as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, Molecular Docking and ADME Studies 340
Synthesis and Biological Evaluation of a Novel Series of Bis-Salicylaldehydes as Mushroom Tyrosinase Inhibitors 330
Comparative study on functional and structural properties of the Barbary sheep and European mouflon haemoglobins 316
Structure-function relationship in a variant haemoglobin: a combined computational-experimental approach 293
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B 293
Structural investigation of pig metmyoglobin by 129Xe NMR spectroscopy 282
Hydroxy derivates of 3-arylcoumarins as tyrosinase inhibitors. 277
Biological Potential of Asphodelus microcarpus Extracts: α-Glucosidase and Antibiofilm Activities In Vitro 222
Supercritical extraction from Rosa canina L. fruits: fatty acids composition and biological activities 171
Design, Synthesis, Structural Insights, Tyrosinase Inhibition, and Sun Protection Factor of New Thiosemicarbazone Derivatives 161
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by Rubus ulmifolius Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes Mellitus 131
Aqueous Extract of Rubus ulmifolius Schott (Rosaceae) against Pathogenic Gram-Positive Oral Bacteria: an in Vitro Evaluation 130
Xanthine Oxidase-Dependent Activation of NLPR3 Inflammasome in Epithelial Cells Sustains Inflammation in Inflammatory Bowel Disease 113
Sustainable Synthesis of 1,2-Disubstituted Benzimidazoles as Promising α-Glucosidase Inhibitors: In Vitro and In Silico Evaluation 94
Fatty acid profile and biological activity of supercritical fluid extract of Rosa canina L. seeds 60
2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents 56
Valorization of Pistacia lentiscus L. Hydrodistillation By-Products: Phytochemical Profile and Multitarget Anti-Aging Activity of an Aqueous Extract 20
Totale 133.681
Categoria #
all - tutte 164.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.176 0 0 0 0 0 0 0 0 0 0 0 1.176
2021/20226.089 947 476 221 553 504 292 177 204 764 694 723 534
2022/20239.201 573 1.256 1.333 829 621 1.129 500 728 529 540 730 433
2023/20249.272 331 381 354 459 766 1.413 1.384 746 567 635 1.075 1.161
2024/202516.342 2.574 3.810 2.770 2.447 1.083 1.268 1.367 119 272 198 173 261
2025/20266.341 423 362 688 574 617 460 890 484 509 772 380 182
Totale 133.681